Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 1
2005 3
2006 3
2007 1
2008 4
2009 2
2011 3
2012 4
2013 6
2014 6
2015 2
2016 5
2017 7
2018 5
2019 10
2020 2
2021 4
2022 6
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
The Prognostic Effect of IKZF1 Deletions in ETV6::RUNX1 and High Hyperdiploid Childhood Acute Lymphoblastic Leukemia.
Østergaard A, Enshaei A, Pieters R, Vora A, Horstmann MA, Escherich G, Johansson B, Heyman M, Schmiegelow K, Hoogerbrugge PM, den Boer ML, Kuiper RP, Moorman AV, Boer JM, van Leeuwen FN. Østergaard A, et al. Among authors: horstmann ma. Hemasphere. 2023 May 4;7(5):e875. doi: 10.1097/HS9.0000000000000875. eCollection 2023 May. Hemasphere. 2023. PMID: 37153875 Free PMC article.
The cracking of Scots pine (Pinus sylvestris) cones.
Horstmann M, Buchheit H, Speck T, Poppinga S. Horstmann M, et al. Front Plant Sci. 2022 Oct 18;13:982756. doi: 10.3389/fpls.2022.982756. eCollection 2022. Front Plant Sci. 2022. PMID: 36330256 Free PMC article.
Amsacrine combined with etoposide and methylprednisolone is a feasible and safe component in first-line intensified treatment of pediatric patients with high-risk acute lymphoblastic leukemia in CoALL08-09 trial.
Mezger K, Ebert S, Muhle HE, Stadt UZ, Borkhardt A, Dilloo D, Faber J, Feuchtinger T, Imschweiler T, Jorch N, Pekrun A, Schmid I, Schramm F, Zimmermann M, Horstmann MA, Escherich G. Mezger K, et al. Among authors: horstmann ma. Pediatr Blood Cancer. 2022 Dec;69(12):e29997. doi: 10.1002/pbc.29997. Epub 2022 Sep 21. Pediatr Blood Cancer. 2022. PMID: 36129234
The Structural and Mechanical Basis for Passive-Hydraulic Pine Cone Actuation.
Eger CJ, Horstmann M, Poppinga S, Sachse R, Thierer R, Nestle N, Bruchmann B, Speck T, Bischoff M, Rühe J. Eger CJ, et al. Among authors: horstmann m. Adv Sci (Weinh). 2022 Jul;9(20):e2200458. doi: 10.1002/advs.202200458. Epub 2022 May 14. Adv Sci (Weinh). 2022. PMID: 35567337 Free PMC article.
An alternative CYB5A transcript is expressed in aneuploid ALL and enriched in relapse.
Bartsch L, Schroeder MP, Hänzelmann S, Bastian L, Lázaro-Navarro J, Schlee C, Tanchez JO, Schulze V, Isaakidis K, Rieger MA, Gökbuget N, Eckert C, Serve H, Horstmann M, Schrappe M, Brüggemann M, Baldus CD, Neumann M. Bartsch L, et al. Among authors: horstmann m. BMC Genom Data. 2022 Apr 18;23(1):30. doi: 10.1186/s12863-022-01041-1. BMC Genom Data. 2022. PMID: 35436854 Free PMC article.
Clofarabine increases the eradication of minimal residual disease of primary B-precursor acute lymphoblastic leukemia compared to high-dose cytarabine without improvement of outcome. Results from the randomized clinical trial 08-09 of the Cooperative Acute Lymphoblastic Leukemia Study Group.
Escherich G, Zur Stadt U, Borkhardt A, Dilloo D, Faber J, Feuchtinger T, Imschweiler T, Jorch N, Pekrun A, Schmid I, Schramm F, Spohn M, Zimmermann M, Horstmann MA. Escherich G, et al. Among authors: horstmann ma. Haematologica. 2022 May 1;107(5):1026-1033. doi: 10.3324/haematol.2021.279357. Haematologica. 2022. PMID: 34348455 Free PMC article. Clinical Trial.
75 results